These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

983 related items for PubMed ID: 11606477

  • 1. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S, Tegeder I, Niederberger E, Bräutigam L, Geisslinger G.
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [Abstract] [Full Text] [Related]

  • 2. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
    Maier TJ, Schilling K, Schmidt R, Geisslinger G, Grösch S.
    Biochem Pharmacol; 2004 Apr 15; 67(8):1469-78. PubMed ID: 15041464
    [Abstract] [Full Text] [Related]

  • 3. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
    Cui W, Yu CH, Hu KQ.
    Clin Cancer Res; 2005 Nov 15; 11(22):8213-21. PubMed ID: 16299255
    [Abstract] [Full Text] [Related]

  • 4. Evidence of COX-2 independent induction of apoptosis and cell cycle block in human colon carcinoma cells after S- or R-ibuprofen treatment.
    Janssen A, Maier TJ, Schiffmann S, Coste O, Seegel M, Geisslinger G, Grösch S.
    Eur J Pharmacol; 2006 Jul 01; 540(1-3):24-33. PubMed ID: 16730702
    [Abstract] [Full Text] [Related]

  • 5. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS, Davis TW, Ornberg RL, Masferrer JL.
    Cancer Res; 2002 Nov 15; 62(22):6706-11. PubMed ID: 12438270
    [Abstract] [Full Text] [Related]

  • 6. Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway.
    Jiang XH, Lam SK, Lin MC, Jiang SH, Kung HF, Slosberg ED, Soh JW, Weinstein IB, Wong BC.
    Oncogene; 2002 Sep 05; 21(39):6113-22. PubMed ID: 12203123
    [Abstract] [Full Text] [Related]

  • 7. Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models.
    Williams CS, Watson AJ, Sheng H, Helou R, Shao J, DuBois RN.
    Cancer Res; 2000 Nov 01; 60(21):6045-51. PubMed ID: 11085526
    [Abstract] [Full Text] [Related]

  • 8. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N.
    Clin Cancer Res; 2005 Sep 15; 11(18):6738-44. PubMed ID: 16166455
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53.
    Swamy MV, Herzog CR, Rao CV.
    Cancer Res; 2003 Sep 01; 63(17):5239-42. PubMed ID: 14500353
    [Abstract] [Full Text] [Related]

  • 10. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Schiffmann S, Maier TJ, Wobst I, Janssen A, Corban-Wilhelm H, Angioni C, Geisslinger G, Grösch S.
    Biochem Pharmacol; 2008 Jul 15; 76(2):179-87. PubMed ID: 18547544
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M, Tsuji S, Tsujii M, Irie T, Komori M, Kimura A, Nishida T, Kakiuchi Y, Kawai N, Murata H, Horimoto M, Sasaki Y, Hayashi N, Kawano S, Hori M.
    Cancer Res; 2003 Oct 15; 63(20):6726-34. PubMed ID: 14583467
    [Abstract] [Full Text] [Related]

  • 12. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
    Patel MI, Subbaramaiah K, Du B, Chang M, Yang P, Newman RA, Cordon-Cardo C, Thaler HT, Dannenberg AJ.
    Clin Cancer Res; 2005 Mar 01; 11(5):1999-2007. PubMed ID: 15756026
    [Abstract] [Full Text] [Related]

  • 13. Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells.
    Niederberger E, Manderscheid C, Grösch S, Schmidt H, Ehnert C, Geisslinger G.
    Biochem Pharmacol; 2004 Jul 15; 68(2):341-50. PubMed ID: 15194006
    [Abstract] [Full Text] [Related]

  • 14. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
    Pyo H, Choy H, Amorino GP, Kim JS, Cao Q, Hercules SK, DuBois RN.
    Clin Cancer Res; 2001 Oct 15; 7(10):2998-3005. PubMed ID: 11595687
    [Abstract] [Full Text] [Related]

  • 15. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, Noguchi K, Sakurai K.
    Int J Oncol; 2003 Sep 15; 23(3):665-72. PubMed ID: 12888902
    [Abstract] [Full Text] [Related]

  • 16. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
    Liu W, Chen Y, Wang W, Keng P, Finkelstein J, Hu D, Liang L, Guo M, Fenton B, Okunieff P, Ding I.
    Am J Clin Oncol; 2003 Aug 15; 26(4):S103-9. PubMed ID: 12902866
    [Abstract] [Full Text] [Related]

  • 17. Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.
    Waskewich C, Blumenthal RD, Li H, Stein R, Goldenberg DM, Burton J.
    Cancer Res; 2002 Apr 01; 62(7):2029-33. PubMed ID: 11929821
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
    Petersen C, Petersen S, Milas L, Lang FF, Tofilon PJ.
    Clin Cancer Res; 2000 Jun 01; 6(6):2513-20. PubMed ID: 10873107
    [Abstract] [Full Text] [Related]

  • 19. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
    Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL.
    Cancer Res; 2002 Feb 01; 62(3):625-31. PubMed ID: 11830509
    [Abstract] [Full Text] [Related]

  • 20. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
    Elder DJ, Halton DE, Hague A, Paraskeva C.
    Clin Cancer Res; 1997 Oct 01; 3(10):1679-83. PubMed ID: 9815550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.